Comparison of BD Vacutainer SST™ Plus Tubes with BD SST™ II Plus Tubes for common analytes

被引:46
作者
Bush, VJ
Janu, MR
Bathur, F
Wells, A
Dasgupta, A
机构
[1] Becton Dickinson & Co, Franklin Lakes, NJ 07417 USA
[2] Concord Repatriat Gen Hosp, Dept Pathol, Concord, NSW 2137, Australia
[3] Univ Texas, Sch Med, Dept Pathol & Lab Med, Houston, TX 77030 USA
关键词
barrier gel; stability; BD SST (TM) II tubes;
D O I
10.1016/S0009-8981(01)00396-5
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Serum separator tubes were introduced 25 years ago and are widely used in the clinical laboratory today for routine collection of blood. These tubes have gained widespread acceptance due to the advantage of the barrier gel that facilitates rapid separation of serum from cellular constituents of blood and thus reduces hemolysis. However, there are some limitations associated with gel tubes (i.e., gel stability and analyte incompatibilities). The serum separator ED SST (TM) tubes manufactured by ED are widely used in clinical laboratories. Recently, ED has developed a new barrier gel, which is superior to the existing gel. We studied the stability of common analytes when serum specimens were stored in the new ED SST (TM) II tubes by comparing the performance with the existing ED SST (TM) tubes. We did not observe any significant reduction in concentrations of 42 commonly ordered analytes using the new ED SST (TM) II tubes. Significant differences were noted at low serum volumes for estradiol in both tube types over time. We conclude that the new ED SST (TM) II tubes are suitable for collection of blood and storage of serum for commonly ordered laboratory tests. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:139 / 143
页数:5
相关论文
共 10 条
[1]  
CLIA 88, 1992, FED REGISTER, V57, P7002
[2]  
DASGUPTA A, 1994, AM J CLIN PATHOL, V101, P456
[3]   Effect of heating human sera at a temperature necessary to deactivate human immunodeficiency virus on measurement of free phenytoin, free valproic acid, and free carbamazepine concentrations [J].
Dasgupta, A ;
Wells, A ;
Chow, L .
THERAPEUTIC DRUG MONITORING, 1999, 21 (04) :421-425
[4]  
Ferry JD, 1999, CLIN CHEM, V45, P1574
[5]  
HILL BM, 1992, CLIN CHEM, V38, P1474
[6]  
LAESSIG RH, 1976, CLIN CHEM, V22, P235
[7]  
LANDT M, 1993, CLIN CHEM, V39, P1712
[8]  
LARSSON L, 1985, CLIN CHEM, V31, P169
[9]  
REINARTZ JJ, 1993, CLIN CHEM, V39, P2535
[10]  
Zhang DBJ, 1998, CLIN CHEM, V44, P1325